Full-Time

VP – Computational Sciences

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Data Science
Machine Learning
AWS
Data Analysis

You match the following Flagship Pioneering's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD in Computational Biology, Bioinformatics, Computer Science, or a related field
  • Significant experience (8+ years) in computational biology or a related field with at least 4 years in a leadership role
  • Proven track record of successfully leading and building high-performing teams
  • Extensive experience with machine learning, data science, integration and analysis of NGS data
  • Experience with NGS and bioinformatics tools
  • Experience with cloud environments such as AWS
  • Ability to develop and execute strategic plans, driving the Platform vision with key stakeholders
  • Excellent communication, interpersonal, and organizational skills
  • Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities simultaneously
Responsibilities
  • Help define and implement strategic, operational and financial plans for the computational platform aligned with Ampersand’s goals of driving AND-Body therapeutics
  • Mentor, inspire, and build a high-performing computational team, promoting professional growth and development
  • Lead efforts to implement and advance new technologies and analyses across the computational platform, working closely with the other scientific teams to generate and interpret high quality data sets for machine learning and platform development
  • Work closely with program heads to establish data infrastructure and analytical workflows
  • Work with computational and experimental scientists to establish data management practices and SOPs to improve efficiency
  • Communicate strategy and results to internal and external parties in verbal, written, and presentation formats, with clear data visualizations
  • Contribute meaningfully to building a world-class AND-Body platform at the forefront of scientific innovation
Desired Qualifications
  • Experience with antibody binder design and multi-omics data analysis

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.
  • Strategic partnerships with Pfizer enhance drug discovery and development capabilities.
  • Inari Agriculture's $2.17 billion valuation highlights successful investment strategy.

What critics are saying

  • Over-reliance on strategic partnerships with large pharmaceutical companies poses potential risks.
  • High-profile executive appointments may lead to cultural clashes within teams.
  • Focus on first-in-category ventures may result in higher R&D costs and longer profitability timelines.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • Combines innovative capacity, entrepreneurial leadership, and capital management in one enterprise.
  • Uses evolutionary methodology to navigate from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.

Bloomberg
Jan 7th, 2025
Ag Tech Startup Inari Gets $2.17 Billion Valuation in Latest Funding Round

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a roughly 32% jump from a prior mark of $1.65 billion set last January.

Contract Pharma
Nov 21st, 2024
Flagship Pioneering Enters Agreements Under Strategic Pfizer Pact

Flagship Pioneering, a bioplatform company, entered agreements with Ampersand Biomedicines and Montai Therapeutics to identify targeted molecules that could be further developed as treatments for obesity and non-small cell lung cancer (NSCLC).